SlideShare a Scribd company logo
Quantifying the economic value of diagnostics in wound care in the UK
Leo Nherera, Health Economics Manager, Systagenix, UK
Louise Digby, Paolo Di Vincenzo , Jane Clark, Chris Gilpin, Systagenix, UK 
EP503 EWMA May 2013
AIM:
Chronic wounds present a significant financial and resource burden to the NHS. The annual cost of 
wound care in the UK has been estimated to be £2 million per 100,000 population. A recent study 
found that 28% of all non‐healing chronic wounds had elevated protease activity (EPA), which can now 
be assessed using a new point of care protease test*, and that these wounds had only a 10% chance of 
healing without appropriate intervention. A separate study showed that 77% of venous leg ulcers 
responded to Collagen/ORC therapies, when targeted to wounds with EPA. This work aimed to quantify 
the economic value of testing for EPA and targeting treatment accordingly.
METHODS:
An economic model was developed to calculate the potential saving that could be achieved by 
identifying chronic wounds with EPA and targeting protease modulating treatment** accordingly. 
Published effectiveness data and UK relevant resource use data were used to populate the model.
RESULTS & CONCLUSIONS:
The model estimated potential savings of £1,906 per EPA wound identified when compared to usual 
care. This equates to over £50,000 for every 100 non‐healing chronic wounds tested.
The model demonstrates that implementing a ‘test and treat’ algorithm of care in the UK involving 
testing for EPA and targeting protease modulating treatment accordingly can achieve savings while 
dramatically improving the healing chances of EPA wounds, thus confirming previously published 
consensus opinion on this topic.
*WOUNDCHEK™ Protease Status
**PROMOGRAN® / PROMOGRAN PRISMA®
C1418
Background: The burden of chronic wounds
There are around 200,000 chronic wounds in the UK and they represent a significant 
burden to the patient and NHS1
One study estimated annual costs for all wounds to be £2.03 Million per 100,000 
population, based on 2006‐2007 prices2
Chronic wounds are estimated to cost the NHS around £2.3‐3.1bn 2006 prices – 3% of NHS 
budget1, however with proper diagnosis and treatment much of the disease burden can be 
avoided
Chronic wounds contain a hostile biochemical environment including elevated  levels of 
inflammatory cytokines, free radicals and proteases irrespective of the underlying 
aetiology 3,4 
Many studies have investigated the role of proteases in human chronic wounds, and have 
concluded that elevated protease activity contributes to their chronicity 5,6,
Posnett J Franks P (2008) The burden of chronic wounds in the UK. Nursing Times 104(3) 44‐5
Vowden K, Vowden P. Posnett J (2009) The resource cost of wound care in the Bradford and Airedale primary care trust in the UK. Journal of wound care 18(3) 
93‐102
M. Muller, C. Trocme, B. Lardy, F. Morel, S. Halimi, P. Y. Benhamou Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP‐1 to TIMP‐1 is a 
predictor of wound healing. Diabetic Medicine (2008) 25(4):419‐426.  
Trengove NJ, Stacey MC, MacAuley S, Bennet N, Gibson J, Burslem F, Murphy G, Schultz G. Analysis of the acute and chronic wound environments: the role of 
A chronic wound with EPA has only a 10% chance of healing without appropriate 
intervention1, however there are no visual cues to detect EPA2
Until recently, there has been no point of care (POC) diagnostic test to detect EPA in 
chronic wounds in routine clinical practice
Without the aid of targeted diagnostics, decision making  is largely based upon 
intuition; this may often lead to inappropriate treatment choices and the use of 
advanced therapies as “last resorts”1
A point of care test* is now available to detect EPA
In an International consensus document, experts agree that the introduction of a POC 
diagnostic tool to detect EPA could aid a more structured, cost‐effective and timely 
approach to wound management3
Background: elevated protease activity (EPA) and chronic wounds
Methods: Clinical assumptions
An economic model was developed to calculate the potential saving that could be achieved 
by identifying chronic wounds with EPA and targeting protease modulating treatment 
accordingly.
Serena T et al (2011) Protease activity levels associated with healing status of chronic wounds. Poster Wounds UK
Cullen, B., Gibson, M., Nesbit, L. Targeted use of protease modulating dressings improves clinical outcomes. Presented at Wounds UK, Harrogate 2011.
Prevalence of EPA: 28% of non‐healing chronic wounds1
(n=28)
NON‐DIRECTED TREATMENT*:
Healing probability of chronic wound 
with EPA:  10% (without appropriate 
intervention)1
EPA DETECTED  TARGETED TREATMENT**:
Healing probability of chronic wound with 
EPA: 77% based on response rate at 4 
weeks2
All non‐healing chronic wounds (n=100)
All other wounds (low 
protease activity) – not 
followed by economic model 
i.e. offered standard care
Today / Baseline: Future scenario:
Assumed healing times: Healing = 12 weeks3; Non‐healing 52 weeks4
Methods: Cost assumptions
NON‐DIRECTED 
TREATMENT*:
• Current total 
cost of care: £96 
/ visit1
• One dressings 
change per week
EPA DETECTED  TARGETED TREATMENT**:
• Cost to detect EPA: £21.50 per test2 (avg 3.6 wounds tested to detect 
1 wound with EPA = 28% prevalence)
• Targeted protease modulating treatment**: incremental costs 
£5.19/dressing change3 in addition to standard costs of care
• Healing wounds / responders: Two (2) dressing changes per week 
during a six (6) week targeted treatment period, followed by standard 
care to healing
• Non‐healing wounds / non‐responders: Two (2) dressing changes per 
week until wound identified as non‐healing after four (4) weeks, then 
return to standard care
Today / Baseline:
Future scenario:
Chronic wounds with EPA
= £202.38 per week
(during protease modulating treatment)
= £96 per week 
(during standard care)
Methods: Economic Model
Standard Care
(non targeted treatment)
TEST & TREAT
(targeted treatment)
Potential cost 
savings
Cost of detecting EPA £0 100 wounds x £21.50 =
£2,150
Cost of healing 
wounds with EPA
10% x 28% x 100 wounds 
x 12 weeks x £96
= £3,226
77% x 28% x 100 wounds x 
6 weeks x £202.38 = 
£26,180
+
77% x 28% x 100 wounds x 
6 weeks x £96 = £12,419
= £38,599
Cost of non‐healing
wounds with EPA
90% x 28% x 100 wounds 
x 52 weeks x £96
= £125,798
23% x 28% x 100 wounds x 
4 weeks x £202.38 = £5,213
+
23% x 28% x 100 wounds x  
48 weeks x £96 = £29,676
= £34,889
Total cost £129,024 £75,637 ‐£53,387
Results: Clinical Value 
Based on the healing probability and EPA prevalence assumptions 
input, out of 100 non healing chronic wounds, the model estimates 
3
22
0
5
10
15
20
25
30
Standard Care TEST & TREAT
(targeted treatment)
Non‐healing wounds
Healing wounds
Number of wounds with EPA
Results: Economic Value
£0
£15.000
£30.000
£45.000
£60.000
£75.000
£90.000
£105.000
£120.000
£135.000
Standard care TEST & TREAT (targeted
treatment)
Costs of treatment and testing for 
wounds with EPA
Cost of WOUNDCHEK™ 
Total cost of non‐healing wounds
Cost of healing wounds
£53,387 total potential cost savings per 100 wounds tested
= £1,906 potential cost savings per EPA wound identified
This frees up 556 clinical episodes
£129,024
£75,637 97.5%
2.5%
2.8%
46.2%
51%
Results: Assessing cost‐effectiveness of TEST & TREAT algorithm
Increasing costs (£)
Increased healing/response
More expensive & effective 
“evaluate”
No testing for EPA
Current Standard Care
ecreased healing/response
ore expensive & less effective 
“Abandon or reject”
Less expensive & less 
effective “evaluate”
Less expensive & more 
effective “Encourage or accept”
TEST & TREAT algorithm
facilitated by testing for EPA*
lies in this quadrant
Conclusions
An economic model (based on 100 non‐healing chronic wounds) has 
shown that implementing a ‘TEST & TREAT’ algorithm in the UK to test 
chronic wounds for EPA and provide targeted protease modulating 
treatment for those wounds with EPA...
 ... could result in 19 additional healing wounds, 
 while enabling potential cost savings of over £50,000, 
 i.e. a potential savings of £1,906 per EPA wound identified, 
 or 556 episodes of care freed up, 
 or £7,229 cash release (dressing materials).
TEST &TREAT algorithm is therefore a dominant strategy with regard 
to cost‐effectiveness when compared to the current standard care and 
the test is self funding

More Related Content

Similar to EWMA 2013 - Ep503 - Quantifying the economic value of diagnostics in wound care in the UK

COST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKE
COST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKECOST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKE
COST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKE
Dr. Raghavendra Kumar Gunda
 
Journal readingg
Journal readinggJournal readingg
Journal readingg
michelle mi
 
Making the case for cost-effective wound management
Making the case for cost-effective wound managementMaking the case for cost-effective wound management
Making the case for cost-effective wound management
GNEAUPP.
 
COST-EFFECTIVENESS ANALYSIS OF AMBULATORY CARE STRATEGY FOR PATIENTS WITHTRAN...
COST-EFFECTIVENESS ANALYSIS OF AMBULATORY CARE STRATEGY FOR PATIENTS WITHTRAN...COST-EFFECTIVENESS ANALYSIS OF AMBULATORY CARE STRATEGY FOR PATIENTS WITHTRAN...
COST-EFFECTIVENESS ANALYSIS OF AMBULATORY CARE STRATEGY FOR PATIENTS WITHTRAN...
ELISA HERNANDEZ TORRES
 
PGD Decolonisation to Reduce Spinal Infection Rates
PGD Decolonisation to Reduce Spinal Infection RatesPGD Decolonisation to Reduce Spinal Infection Rates
PGD Decolonisation to Reduce Spinal Infection Rates
Annesha Archyangelio MSc BSc RN ILM PhD Student
 
Final intro use of economic methods for injury prevention resource allocation
Final intro use of economic methods for injury prevention resource allocation Final intro use of economic methods for injury prevention resource allocation
Final intro use of economic methods for injury prevention resource allocation
John Wren
 
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Office of Health Economics
 
All.Can report FINAL single page spread Jan2017
All.Can report FINAL single page spread Jan2017All.Can report FINAL single page spread Jan2017
All.Can report FINAL single page spread Jan2017
Daniel Mansuk Han
 
Best practice wound care
Best practice wound careBest practice wound care
Best practice wound care
GNEAUPP.
 
Cea presentation, tb case finding
Cea presentation, tb case findingCea presentation, tb case finding
Cea presentation, tb case finding
MUHOOZI MICHAEL
 
Cancereconomics
CancereconomicsCancereconomics
Cancereconomics
robertocarrion177
 
Genomics strategy and implementation in the NHS in England
Genomics strategy and implementation in the NHS in EnglandGenomics strategy and implementation in the NHS in England
Genomics strategy and implementation in the NHS in England
Health Innovation Wessex
 
Cost-effectiveness of electroconvulsive therapy compared to repetitive transc...
Cost-effectiveness of electroconvulsive therapy compared to repetitive transc...Cost-effectiveness of electroconvulsive therapy compared to repetitive transc...
Cost-effectiveness of electroconvulsive therapy compared to repetitive transc...
Pydesalud
 
Ispor cost effectiveness_analysis_gm
Ispor cost effectiveness_analysis_gmIspor cost effectiveness_analysis_gm
Ispor cost effectiveness_analysis_gm
Office of Health Economics
 
Global landscape of glioblastoma multiforme management in the stupp protocol ...
Global landscape of glioblastoma multiforme management in the stupp protocol ...Global landscape of glioblastoma multiforme management in the stupp protocol ...
Global landscape of glioblastoma multiforme management in the stupp protocol ...
Ahmad Ozair
 
Renewing health
Renewing healthRenewing health
Renewing health
Annika Sällström
 
Critical Thinking Case Study – Cost Containment (120 points)C.docx
Critical Thinking Case Study – Cost Containment (120 points)C.docxCritical Thinking Case Study – Cost Containment (120 points)C.docx
Critical Thinking Case Study – Cost Containment (120 points)C.docx
mydrynan
 
Vitiligo Research review apr-jun_2012
Vitiligo Research review apr-jun_2012Vitiligo Research review apr-jun_2012
Vitiligo Research review apr-jun_2012
VR Foundation
 
Valuing Trial Designs from a Pharmaceutical Perspective using Value Based Pri...
Valuing Trial Designs from a Pharmaceutical Perspective using Value Based Pri...Valuing Trial Designs from a Pharmaceutical Perspective using Value Based Pri...
Valuing Trial Designs from a Pharmaceutical Perspective using Value Based Pri...
ScHARR HEDS
 
Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and cons
PM Society
 

Similar to EWMA 2013 - Ep503 - Quantifying the economic value of diagnostics in wound care in the UK (20)

COST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKE
COST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKECOST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKE
COST-EFFECTIVENESS ANALYSIS IN THE MANAGEMENT OF STROKE
 
Journal readingg
Journal readinggJournal readingg
Journal readingg
 
Making the case for cost-effective wound management
Making the case for cost-effective wound managementMaking the case for cost-effective wound management
Making the case for cost-effective wound management
 
COST-EFFECTIVENESS ANALYSIS OF AMBULATORY CARE STRATEGY FOR PATIENTS WITHTRAN...
COST-EFFECTIVENESS ANALYSIS OF AMBULATORY CARE STRATEGY FOR PATIENTS WITHTRAN...COST-EFFECTIVENESS ANALYSIS OF AMBULATORY CARE STRATEGY FOR PATIENTS WITHTRAN...
COST-EFFECTIVENESS ANALYSIS OF AMBULATORY CARE STRATEGY FOR PATIENTS WITHTRAN...
 
PGD Decolonisation to Reduce Spinal Infection Rates
PGD Decolonisation to Reduce Spinal Infection RatesPGD Decolonisation to Reduce Spinal Infection Rates
PGD Decolonisation to Reduce Spinal Infection Rates
 
Final intro use of economic methods for injury prevention resource allocation
Final intro use of economic methods for injury prevention resource allocation Final intro use of economic methods for injury prevention resource allocation
Final intro use of economic methods for injury prevention resource allocation
 
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
Developing and Paying for Gene Therapies: Can We Resolve the Conflicts? A Eur...
 
All.Can report FINAL single page spread Jan2017
All.Can report FINAL single page spread Jan2017All.Can report FINAL single page spread Jan2017
All.Can report FINAL single page spread Jan2017
 
Best practice wound care
Best practice wound careBest practice wound care
Best practice wound care
 
Cea presentation, tb case finding
Cea presentation, tb case findingCea presentation, tb case finding
Cea presentation, tb case finding
 
Cancereconomics
CancereconomicsCancereconomics
Cancereconomics
 
Genomics strategy and implementation in the NHS in England
Genomics strategy and implementation in the NHS in EnglandGenomics strategy and implementation in the NHS in England
Genomics strategy and implementation in the NHS in England
 
Cost-effectiveness of electroconvulsive therapy compared to repetitive transc...
Cost-effectiveness of electroconvulsive therapy compared to repetitive transc...Cost-effectiveness of electroconvulsive therapy compared to repetitive transc...
Cost-effectiveness of electroconvulsive therapy compared to repetitive transc...
 
Ispor cost effectiveness_analysis_gm
Ispor cost effectiveness_analysis_gmIspor cost effectiveness_analysis_gm
Ispor cost effectiveness_analysis_gm
 
Global landscape of glioblastoma multiforme management in the stupp protocol ...
Global landscape of glioblastoma multiforme management in the stupp protocol ...Global landscape of glioblastoma multiforme management in the stupp protocol ...
Global landscape of glioblastoma multiforme management in the stupp protocol ...
 
Renewing health
Renewing healthRenewing health
Renewing health
 
Critical Thinking Case Study – Cost Containment (120 points)C.docx
Critical Thinking Case Study – Cost Containment (120 points)C.docxCritical Thinking Case Study – Cost Containment (120 points)C.docx
Critical Thinking Case Study – Cost Containment (120 points)C.docx
 
Vitiligo Research review apr-jun_2012
Vitiligo Research review apr-jun_2012Vitiligo Research review apr-jun_2012
Vitiligo Research review apr-jun_2012
 
Valuing Trial Designs from a Pharmaceutical Perspective using Value Based Pri...
Valuing Trial Designs from a Pharmaceutical Perspective using Value Based Pri...Valuing Trial Designs from a Pharmaceutical Perspective using Value Based Pri...
Valuing Trial Designs from a Pharmaceutical Perspective using Value Based Pri...
 
Patient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and consPatient support programmes within medicines optimisation – the pros and cons
Patient support programmes within medicines optimisation – the pros and cons
 

More from EWMA

EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...
EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...
EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...
EWMA
 
EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...
EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...
EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...
EWMA
 
EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...
EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...
EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...
EWMA
 
EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...
EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...
EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...
EWMA
 
EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...
EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...
EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...
EWMA
 
EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...
EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...
EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...
EWMA
 
Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...
Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...
Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...
EWMA
 
EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...
EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...
EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...
EWMA
 
EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...
EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...
EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...
EWMA
 
EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...
EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...
EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...
EWMA
 
EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...
EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...
EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...
EWMA
 
EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...
EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...
EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...
EWMA
 
EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...
EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...
EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...
EWMA
 
EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...
EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...
EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...
EWMA
 
EWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTS
EWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTSEWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTS
EWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTS
EWMA
 
EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...
EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...
EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...
EWMA
 
EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...
EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...
EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...
EWMA
 
EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...
EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...
EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...
EWMA
 
EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...
EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...
EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...
EWMA
 
EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...
EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...
EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...
EWMA
 

More from EWMA (20)

EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...
EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...
EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...
 
EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...
EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...
EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...
 
EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...
EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...
EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...
 
EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...
EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...
EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...
 
EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...
EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...
EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...
 
EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...
EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...
EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...
 
Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...
Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...
Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...
 
EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...
EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...
EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...
 
EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...
EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...
EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...
 
EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...
EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...
EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...
 
EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...
EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...
EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...
 
EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...
EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...
EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...
 
EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...
EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...
EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...
 
EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...
EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...
EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...
 
EWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTS
EWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTSEWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTS
EWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTS
 
EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...
EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...
EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...
 
EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...
EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...
EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...
 
EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...
EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...
EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...
 
EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...
EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...
EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...
 
EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...
EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...
EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...
 

Recently uploaded

World Population Day 2024_Overview_Dr Bijan Das
World Population Day 2024_Overview_Dr Bijan DasWorld Population Day 2024_Overview_Dr Bijan Das
World Population Day 2024_Overview_Dr Bijan Das
srmnchatripura
 
Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...
Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...
Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...
NephroTube - Dr.Gawad
 
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
CarriePoppy
 
Building a Strong Partnership with Your Medical Team
Building a Strong Partnership with Your Medical TeamBuilding a Strong Partnership with Your Medical Team
Building a Strong Partnership with Your Medical Team
bkling
 
2nd week of Human development .embryology
2nd week of Human development .embryology2nd week of Human development .embryology
2nd week of Human development .embryology
Mithilesh Chaurasia
 
STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...
STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...
STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...
Niranjan Chavan
 
Interpretation of ECG - Cardiac Arrhythmias
Interpretation of ECG - Cardiac ArrhythmiasInterpretation of ECG - Cardiac Arrhythmias
Interpretation of ECG - Cardiac Arrhythmias
MedicoseAcademics
 
Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...
Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...
Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...
Internal medicine department, faculty of Medicine Beni-Suef University Egypt
 
selllllllllllllllllllllllllllllllllllllllllllllll.pptx
selllllllllllllllllllllllllllllllllllllllllllllll.pptxselllllllllllllllllllllllllllllllllllllllllllllll.pptx
selllllllllllllllllllllllllllllllllllllllllllllll.pptx
Joebest8
 
Text Book of Emergency Disaster and Trauma Nursing Book
Text Book of Emergency Disaster and Trauma Nursing  BookText Book of Emergency Disaster and Trauma Nursing  Book
Text Book of Emergency Disaster and Trauma Nursing Book
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
Drug Repurposing for Parasitic Diseases.pptx
Drug Repurposing for Parasitic Diseases.pptxDrug Repurposing for Parasitic Diseases.pptx
Drug Repurposing for Parasitic Diseases.pptx
drebrahiim
 
General Endocrinology and mechanism of action of hormones
General Endocrinology and mechanism of action of hormonesGeneral Endocrinology and mechanism of action of hormones
General Endocrinology and mechanism of action of hormones
MedicoseAcademics
 
Text Book of Operation Theater Nursing OT Nursing
Text Book of Operation Theater Nursing OT NursingText Book of Operation Theater Nursing OT Nursing
Text Book of Operation Theater Nursing OT Nursing
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
Hand Book of Oncology Nursing - Cancer Nursing Book
Hand Book of Oncology Nursing - Cancer Nursing BookHand Book of Oncology Nursing - Cancer Nursing Book
Hand Book of Oncology Nursing - Cancer Nursing Book
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
Text Book of Nursing Concepts - Fundamental of Nursing
Text Book of Nursing Concepts - Fundamental of NursingText Book of Nursing Concepts - Fundamental of Nursing
Text Book of Nursing Concepts - Fundamental of Nursing
BP KOIRALA INSTITUTE OF HELATH SCIENCS,, NEPAL
 
First-Aid-Made-Easy-Training-Presentation (1).pptx
First-Aid-Made-Easy-Training-Presentation (1).pptxFirst-Aid-Made-Easy-Training-Presentation (1).pptx
First-Aid-Made-Easy-Training-Presentation (1).pptx
RichardRMThod
 
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdfNUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
MatsikoAlex
 
How to Relieve Prostate Congestion- Here are some Effective Strategies.pptx
How to Relieve Prostate Congestion- Here are some Effective Strategies.pptxHow to Relieve Prostate Congestion- Here are some Effective Strategies.pptx
How to Relieve Prostate Congestion- Here are some Effective Strategies.pptx
AmandaChou9
 
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Anindya Das Adhikary
 
vaginal thrush presentation by Dr. Rewas Ali
vaginal thrush presentation by Dr. Rewas Alivaginal thrush presentation by Dr. Rewas Ali
vaginal thrush presentation by Dr. Rewas Ali
RewAs ALI
 

Recently uploaded (20)

World Population Day 2024_Overview_Dr Bijan Das
World Population Day 2024_Overview_Dr Bijan DasWorld Population Day 2024_Overview_Dr Bijan Das
World Population Day 2024_Overview_Dr Bijan Das
 
Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...
Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...
Hemodialysis: Chapter 11, Venous Catheter - Basics, Insertion, Use and Care -...
 
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
2024 07 12 Do you share my autistic traits_ - Google Sheets.pdf
 
Building a Strong Partnership with Your Medical Team
Building a Strong Partnership with Your Medical TeamBuilding a Strong Partnership with Your Medical Team
Building a Strong Partnership with Your Medical Team
 
2nd week of Human development .embryology
2nd week of Human development .embryology2nd week of Human development .embryology
2nd week of Human development .embryology
 
STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...
STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...
STRATEGIES FOR RATIONALISING/REDUCING CAESAREAN SECTION RATE BY USE OF "SION ...
 
Interpretation of ECG - Cardiac Arrhythmias
Interpretation of ECG - Cardiac ArrhythmiasInterpretation of ECG - Cardiac Arrhythmias
Interpretation of ECG - Cardiac Arrhythmias
 
Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...
Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...
Subcutaneous nodules in rheumatic diseases Ahmed Yehia Assistant Professor of...
 
selllllllllllllllllllllllllllllllllllllllllllllll.pptx
selllllllllllllllllllllllllllllllllllllllllllllll.pptxselllllllllllllllllllllllllllllllllllllllllllllll.pptx
selllllllllllllllllllllllllllllllllllllllllllllll.pptx
 
Text Book of Emergency Disaster and Trauma Nursing Book
Text Book of Emergency Disaster and Trauma Nursing  BookText Book of Emergency Disaster and Trauma Nursing  Book
Text Book of Emergency Disaster and Trauma Nursing Book
 
Drug Repurposing for Parasitic Diseases.pptx
Drug Repurposing for Parasitic Diseases.pptxDrug Repurposing for Parasitic Diseases.pptx
Drug Repurposing for Parasitic Diseases.pptx
 
General Endocrinology and mechanism of action of hormones
General Endocrinology and mechanism of action of hormonesGeneral Endocrinology and mechanism of action of hormones
General Endocrinology and mechanism of action of hormones
 
Text Book of Operation Theater Nursing OT Nursing
Text Book of Operation Theater Nursing OT NursingText Book of Operation Theater Nursing OT Nursing
Text Book of Operation Theater Nursing OT Nursing
 
Hand Book of Oncology Nursing - Cancer Nursing Book
Hand Book of Oncology Nursing - Cancer Nursing BookHand Book of Oncology Nursing - Cancer Nursing Book
Hand Book of Oncology Nursing - Cancer Nursing Book
 
Text Book of Nursing Concepts - Fundamental of Nursing
Text Book of Nursing Concepts - Fundamental of NursingText Book of Nursing Concepts - Fundamental of Nursing
Text Book of Nursing Concepts - Fundamental of Nursing
 
First-Aid-Made-Easy-Training-Presentation (1).pptx
First-Aid-Made-Easy-Training-Presentation (1).pptxFirst-Aid-Made-Easy-Training-Presentation (1).pptx
First-Aid-Made-Easy-Training-Presentation (1).pptx
 
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdfNUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
NUTRICONNECT NEWSLETTER 3RD ISSUE 2ND VOLUME.pdf
 
How to Relieve Prostate Congestion- Here are some Effective Strategies.pptx
How to Relieve Prostate Congestion- Here are some Effective Strategies.pptxHow to Relieve Prostate Congestion- Here are some Effective Strategies.pptx
How to Relieve Prostate Congestion- Here are some Effective Strategies.pptx
 
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
Amygdala Medi-Trivia Quiz (Prelims) | FAQ 2024
 
vaginal thrush presentation by Dr. Rewas Ali
vaginal thrush presentation by Dr. Rewas Alivaginal thrush presentation by Dr. Rewas Ali
vaginal thrush presentation by Dr. Rewas Ali
 

EWMA 2013 - Ep503 - Quantifying the economic value of diagnostics in wound care in the UK